LiverRight and Aegle Medical Solutions Announce Partnership for Liver Disease Diagnostics

LiverRight and Aegle Medical Solutions have entered into a strategic partnership to integrate non-invasive liver assessment technology with virtual specialist clinical services. This collaboration aims to assist healthcare organizations in establishing or expanding liver care programs by combining diagnostic ultrasound systems with remote hepatology consultations. The initiative seeks to streamline the clinical pathway from initial patient identification and assessment to diagnosis and longitudinal management for individuals with various liver conditions across the United States.

The partnership between Aegle Medical Solutions and LiverRight reflects a growing industry trend toward decentralizing specialized care by equipping primary care and gastroenterology practices with advanced diagnostic tools. By pairing the Mindray Hepatus-Series ultrasound systems—which utilize Visualized Transient Elastography for liver stiffness and steatosis measurements—with a virtual network of hepatology providers, the collaboration attempts to reduce the logistical barriers between initial screening and specialist-led treatment. This model aims to address the diagnostic gap for patients in regions where access to dedicated liver specialists is limited, potentially facilitating earlier interventions for conditions such as metabolic dysfunction-associated steatotic liver disease (MASLD) and other chronic liver disorders.

From an operational standpoint, the integration of these services allows health systems to implement comprehensive liver programs without the necessity of developing internal infrastructure from the ground up. By centralizing the referral and interpretation process through the LiverRight platform, providers may increase the efficiency of patient throughput while maintaining diagnostic consistency. The success of this model will likely depend on the ability of healthcare organizations to incorporate these new workflows into existing outpatient settings effectively. As non-invasive diagnostic technologies continue to evolve, partnerships that bridge the gap between hardware deployment and clinical interpretation may become a standard approach for managing the high prevalence of undiagnosed chronic liver disease in the general population.